Medivolve Inc MEDVF

News or no News this week but we can verify all the info

[Sarb99]

Thanks for your advice but we do not follow QuestCap blindly.  We do our homework; we can even help you verify most of what QuestCap announced through third party links.

 

• Here are testing centres in Las Vegas by Collection Sites LLC 100% owned by QuestCap. Collection Sites has launched COVID-19 testing services in conjunction with Alcala Testing and Analysis Services, a CLIA-registered high-complexity laboratory based in San Diego, Calif: Nevada Governor's Office & Nevada Department of Health and Human Services. https://nvhealthresponse.nv.gov/find-covid-19-testing-in-nevada/

• Here is Xtreme Cubes Corp https://www.xtremecubes.com/ which is part of large origination called Ahern family of companies https://www.aherncompanies.com/ do you really think, they will their band name reputation online for penny stock BS, No way. They do offer Xtreme Cube’s COVID-19 Modular Solutions. That is what QuestCap ordered 165 of them.

• Done deal, $3 million USD, and about $3.9 Canadian in account: MTJR has completed the sale of 750,000 PCL Rapid Gold COVID-19 IgG/IgM Antibody tests to Breeze Laboratories, a medical manufacturing company with well-developed distribution channels, for US$4.00 per test. The proceeds from the sale will be returned to QuestCap and used to repay its outstanding US$7.7 million loan commitment. https://stockhouse.com/news/press-releases/2020/08/28/mtjr-sells-750-000-covid-19-igg-igm-antibody-tests-in-colombia

• QuestCap Inc. (“QuestCap”) (CSE:QSC; FRA:34C1), its wholly-owned subsidiary, Collection Sites LLC, and RESAAS Services Inc. (“RESAAS”) (TSX-V: RSS, OTCQB: RSASF) are pleased to confirm the companies have entered into an agreement to sell U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) COVID-19 Rapid Tests to real estate sales professionals across the United States through RESAAS’ global real estate platform. https://corporate.resaas.com/news-releases/2020/08/26/resaas-and-questcap-enter-into-commercial-agreement-to-sell-fda-eua-covid-19-igg-igm-antibody-tests/

• QuestCap Enters Binding Agreement to Acquire 28% Interest in Colombian Full-Service Medical Clinic. https://www.sanatyips.com/ Here is selling covid-19 through social media https://www.facebook.com/ipssanaty News in Columbia https://www.financecolombia.com/questcap-social-impact-investors-take-28-stake-in-colombian-health-clinic-sanaty-ips/

• QuestCap Inc announced today it is partnering with Sinai Health Foundation to support the development of a diagnostic test for COVID-19. https://themarketherald.ca/questcap-developing-coronavirus-test-with-sinai-health-2020-04-09/ Sinai Health antibody test detects past COVID-19 infection and quality of immune response https://www.sinaihealth.ca/news/sinai-health-antibody-test-detects-past-covid-19-infection-and-quality-of-immune-response/ Sinai Health researchers develop robotic system to survey for widespread exposure to COVID-19 https://www.theglobeandmail.com/business/technology/science/article-robotic-system-to-survey-for-widespread-exposure-to-covid-19/

• QUESTCAP Is pleased to announce an investment of $1 million in the Sunnybrook Research Institute’s COVID-19 research. With these funds, Sunnybrook will establish the Sunnybrook Translational Research Group for Emerging and Respiratory Viruses (“SERV”) and QuestCap will receive a 3.5% royalty on any revenues earned by Sunnybrook from the commercialization of any of the research done by SERV. https://sunnybrook.ca/foundation/media/item.asp?c=3&i=2100&f=covid-19-community-response Samira Mubareka is also advise Canadian Govt Therapeutics Task Force science advisors: https://www.ic.gc.ca/eic/site/lsg-pdsv.nsf/eng/hn01780.html